Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Transfusion In Pregnant Women With Sickle Cell Disease
NCT06979492Phase 4Withdrawn
- Sponsor
- Emory University
- Start
- Sep 2026
- Primary completion
- May 2028
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of red blood cell transfusion in sickle cell disease (SCD) (3 arms), sponsored by Emory University. Primary endpoints: Hospital admissions rate, Number of maternal emergency department (ED)/Acute care visits and 3 more. Planned start Sep 2026; status: withdrawn.
02
Drugs
red blood cell transfusion
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT06979492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06979492.